Oncology First-line Treatment of Chronic Lymphocytic Leukemia: Building on the Data expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
Oncology Scientific Advancements in the Treatment of Chronic Lymphocytic Leukemia expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
Oncology High-Risk Chronic Lymphocytic Leukemia: TP53 Aberrancy in Focus expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
Oncology Unmet Needs in Chronic Lymphocytic Leukemia expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
Oncology The Future of Chronic Lymphocytic Leukemia Management expert roundtables By Ian W. Flinn, MD, PhD; Jeff Sharman, MD; John C. Byrd, MD
